This inventor holds 11 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Biohaven Therapeutics Ltd., Biohaven Pharmaceutical Holding Company Limited, Rutgers, The State University of New Jersey. Active years: 2017-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
8 out of 32 
3 out of 8 
1 out of 1,496 
Years Active: 2017-2025
Title: Innovations and Contributions of Jeffery Claude Pelletier
Introduction
Jeffery Claude Pelletier, based in Lafayette Hill, PA, is a notable inventor with a substantial portfolio of ten patents to his name. His work primarily revolves around pharmaceutical innovations aimed at treating various medical conditions, including cancers and neurological disorders.
Latest Patents
Among his latest patents, one is focused on "Riluzole prodrugs and their use." This invention encompasses pharmaceutical compositions that include substituted riluzole prodrugs designed for the treatment of cancers such as melanoma, breast cancer, brain cancer, and prostate cancer. These prodrugs are engineered for enhanced stability against hepatic metabolism and are effectively administered orally, releasing riluzole into systemic circulation.
Another significant patent involves "Acyl benzo[d]thiazol-2-amine and their methods of use." This invention presents acyl benzo[d]thiazol-2-amines which may serve as valuable therapeutics for various diseases, including neurological disorders like amyotrophic lateral sclerosis and bipolar disorder, as well as treatment-resistant and major depression, general anxiety disorder, and cancers including melanoma, breast cancer, brain cancer, and prostate cancer.
Career Highlights
Throughout his career, Pelletier has been affiliated with prominent companies in the pharmaceutical industry, including Biohaven Therapeutics Ltd. and Biohaven Pharmaceutical Holding Company Limited. His contributions to these organizations underscore his commitment to advancing medical science and improving patient outcomes through innovative drug development.
Collaborations
Jeffery Pelletier has worked alongside esteemed colleagues such as Allen B. Reitz and Jay Edward Wrobel. These collaborations have contributed to enriching his research endeavors and enhancing the quality of his inventions, paving the way for advancements in therapeutic options for a range of health conditions.
Conclusion
Jeffery Claude Pelletier stands out as a prolific inventor whose work has the potential to transform treatment methodologies for complex diseases. With a focus on pharmaceutical innovations, his contributions through patents embody a significant leap in medical science and showcase his dedication to improving healthcare outcomes for patients facing challenging diagnoses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile